Cargando…

Guanine-Based Purines as an Innovative Target to Treat Major Depressive Disorder

Detalles Bibliográficos
Autores principales: Almeida, Roberto F., Ferreira, Tiago P., David, Camila V. C., Abreu e Silva, Paulo C., dos Santos, Sulamita A., Rodrigues, Ana L. S., Elisabetsky, Elaine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076783/
https://www.ncbi.nlm.nih.gov/pubmed/33927625
http://dx.doi.org/10.3389/fphar.2021.652130
_version_ 1783684756252131328
author Almeida, Roberto F.
Ferreira, Tiago P.
David, Camila V. C.
Abreu e Silva, Paulo C.
dos Santos, Sulamita A.
Rodrigues, Ana L. S.
Elisabetsky, Elaine
author_facet Almeida, Roberto F.
Ferreira, Tiago P.
David, Camila V. C.
Abreu e Silva, Paulo C.
dos Santos, Sulamita A.
Rodrigues, Ana L. S.
Elisabetsky, Elaine
author_sort Almeida, Roberto F.
collection PubMed
description
format Online
Article
Text
id pubmed-8076783
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80767832021-04-28 Guanine-Based Purines as an Innovative Target to Treat Major Depressive Disorder Almeida, Roberto F. Ferreira, Tiago P. David, Camila V. C. Abreu e Silva, Paulo C. dos Santos, Sulamita A. Rodrigues, Ana L. S. Elisabetsky, Elaine Front Pharmacol Pharmacology Frontiers Media S.A. 2021-04-13 /pmc/articles/PMC8076783/ /pubmed/33927625 http://dx.doi.org/10.3389/fphar.2021.652130 Text en Copyright © 2021 Almeida, Ferreira, David, Abreu e Silva, dos Santos, Rodrigues and Elisabetsky. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Almeida, Roberto F.
Ferreira, Tiago P.
David, Camila V. C.
Abreu e Silva, Paulo C.
dos Santos, Sulamita A.
Rodrigues, Ana L. S.
Elisabetsky, Elaine
Guanine-Based Purines as an Innovative Target to Treat Major Depressive Disorder
title Guanine-Based Purines as an Innovative Target to Treat Major Depressive Disorder
title_full Guanine-Based Purines as an Innovative Target to Treat Major Depressive Disorder
title_fullStr Guanine-Based Purines as an Innovative Target to Treat Major Depressive Disorder
title_full_unstemmed Guanine-Based Purines as an Innovative Target to Treat Major Depressive Disorder
title_short Guanine-Based Purines as an Innovative Target to Treat Major Depressive Disorder
title_sort guanine-based purines as an innovative target to treat major depressive disorder
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076783/
https://www.ncbi.nlm.nih.gov/pubmed/33927625
http://dx.doi.org/10.3389/fphar.2021.652130
work_keys_str_mv AT almeidarobertof guaninebasedpurinesasaninnovativetargettotreatmajordepressivedisorder
AT ferreiratiagop guaninebasedpurinesasaninnovativetargettotreatmajordepressivedisorder
AT davidcamilavc guaninebasedpurinesasaninnovativetargettotreatmajordepressivedisorder
AT abreuesilvapauloc guaninebasedpurinesasaninnovativetargettotreatmajordepressivedisorder
AT dossantossulamitaa guaninebasedpurinesasaninnovativetargettotreatmajordepressivedisorder
AT rodriguesanals guaninebasedpurinesasaninnovativetargettotreatmajordepressivedisorder
AT elisabetskyelaine guaninebasedpurinesasaninnovativetargettotreatmajordepressivedisorder